Monthly Archives:
December, 2013


  1. Ben Franklin to Invest $342,378 In Regional Economic Development

    The Ben Franklin Technology Partners of Northeastern Pennsylvania’s (BFTP/NEP) Board of Directors has approved the investment of $342,378 in support of regional economic development. BFTP/NEP’s goal is to help lead northeastern Pennsylvania to a better economic future by building partnerships that develop and apply technology for competitive advantage. To achieve this goal, Ben Franklin staff Continue Reading…

  2. Ben Franklin client Saladax at Forefront of Customized Medication

    There is a growing realization that enabling physicians to take a personalized approach to treatment decisions can dramatically improve clinical outcomes, reduce adverse-drug related events, and improve patients’ quality of life. Read more.  Saladax – Bethlehem Co at Forefront of Customized Medication 12-9-13

  3. Keystone Edge Feature: Ben Franklin Venture Idol

    With a laser focus, a clear grasp of its market, realistic goals and a strategy for achieving them, Bethlehem’s Pivitec has emerged as the 2013 Ben Franklin Venture Idol. Read more.

  4. Ben Franklin Client Cernostics Raises $1.4 Million in Series B Round

    Cernostics’ Series B funding will further develop a breakthrough diagnostic platform, producing comprehensive risk prediction for the development of esophageal cancer in patients with Barrett’s Esophagus. Read more.

  5. Berkshire Blanket Partners with Ben Franklin Alumnus X-STATIC®

    Silver fiber technology provides antimicrobial, temperature regulating, and odor resistant benefits to baby blankets and apparel. Berkshire Blanket, a leading brand of premium quality blankets, throws, and soft home goods, introduces its new Forever Safe™ collection of baby blankets, apparel and accessories featuring X-STATIC®, a product of Noble Biomaterials. Forever Safe products with X-STATIC® help Continue Reading…

  6. Ben Franklin Alumnus Particle Sciences wins contract to treat Traumatic Brain Injury

    Particle Sciences has been tasked with creating a nasal formulation of the steroid hormone progesterone that can be used to treat patients who have suffered traumatic brain injury. Read more.